Interferon Beta Biosimilar Recombinant Protein (IFNAR1) for Research

Cat No.: GMP-Bios-INN-873

Pre-Made Interferon Beta Biosimilar, Recombinant Protein targeting IFNAR1: Recombinant therapeutic protein targeting AVP/IFN-alpha-REC/IFNAR/IFNBR/IFRC is a biosimilar expressed by mammalian cell line as a benchmark reference therapeutic antibody for biological drug disovery items including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.

Interferon beta is a cytokine in the interferon family used to treat multiple sclerosis (MS)

Order Information

* GeneMedi provides NON-PROFIT PRICE to support Academic research. Please click inquiry for product quotation. →
Catalog No. Package Price(In USD)
GMP-Bios-INN-873-1mg 1mg 3090
GMP-Bios-INN-873-10mg 10mg
GMP-Bios-INN-873-100mg 100mg
GMP-Bios-INN-873-xmg ≥100mg



Product Details

Products Name (INN Index) Pre-Made Interferon Beta Biosimilar, Recombinant Protein targeting IFNAR1: Recombinant therapeutic protein targeting AVP/IFN-alpha-REC/IFNAR/IFNBR/IFRC
INN Name Interferon Beta
TargetIFNAR1
FormatRecombinant Protein
Derivation0
Species Reactivityhuman
CH1 IsotypeIFNB1 (interferon beta 1, IFNB) *a (C38) 22-187
VD LCIFNB1 (interferon beta 1, IFNB) *a (C38) 22-187
Highest_Clin_Trial (Jan '20)
Est. Status
100% SI Structure
99% SI Structure
95-98% SI Structure
Year Proposed
Year Recommended
CompaniesBiogen, Inc. (Cambridge MA USA) / Merck Serono International S.A. (Geneva Switzerland)
Conditions Approved
Conditions Active
Conditions Discontinued
Development Tech0



About target - IFNAR1

1. Protein Interferon alpha/beta receptor 1

2. Gene IFNAR1

3. Organism Homo sapiens (Human)

Function

Component of the receptor for type I interferons, including interferons alpha, IFNB1 and IFNW1 (PubMed:2153461, PubMed:7665574, PubMed:10049744, PubMed:14532120, PubMed:15337770, PubMed:21854986).

Functions in general as heterodimer with IFNAR2 (PubMed:7665574, PubMed:10049744, PubMed:21854986).

Type I interferon binding activates the JAK-STAT signaling cascade, and triggers tyrosine phosphorylation of a number of proteins including JAKs, TYK2, STAT proteins and the IFNR alpha- and beta-subunits themselves (PubMed:7665574, PubMed:21854986, PubMed:32972995).

Can form an active IFNB1 receptor by itself and activate a signaling cascade that does not involve activation of the JAK-STAT pathway (By similarity).